A Safety and Efficacy Study of DE-120 Injectable Solution for Age-related Macular Degeneration

Clinical trial NCT02401945 · COMPLETED

Trial details

NCT number: NCT02401945
Sponsor: Santen Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Age-Related Macular Degeneration

Start date: 2015-04-01
Primary completion: 2016-06-22
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.